Nina Rogelius - Publications

Affiliations: 
Wallenberg Neuroscience Center, Lund University, Lund, Skåne län, Sweden 

4/6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Sørensen AT, Rogelius N, Lundberg C, Kokaia M. Activity-dependent long-term plasticity of afferent synapses on grafted stem/progenitor cell-derived neurons. Experimental Neurology. 229: 274-81. PMID 21324317 DOI: 10.1016/J.Expneurol.2011.02.008  0.595
2008 Rogelius N, Hebsgaard JB, Lundberg C, Parmar M. Reprogramming of neonatal SVZ progenitors by islet-1 and neurogenin-2. Molecular and Cellular Neurosciences. 38: 453-9. PMID 18524626 DOI: 10.1016/J.Mcn.2008.04.008  0.635
2006 Rogelius N, Jensen JB, Lundberg C, Parmar M. Retrovirally delivered Islet-1 increases recruitment of Ng2 expressing cells from the postnatal SVZ into the striatum. Experimental Neurology. 201: 388-98. PMID 16806175 DOI: 10.1016/J.Expneurol.2006.04.022  0.678
2005 Rogelius N, Ericson C, Lundberg C. In vivo labeling of neuroblasts in the subventricular zone of rats. Journal of Neuroscience Methods. 142: 285-93. PMID 15698668 DOI: 10.1016/J.Jneumeth.2004.09.008  0.51
Low-probability matches (unlikely to be authored by this person)
2023 Kirkeby A, Nelander J, Hoban DB, Rogelius N, Bjartmarz H, Storm P, Fiorenzano A, Adler AF, Vale S, Mudannayake J, Zhang Y, Cardoso T, Mattsson B, Landau AM, Glud AN, et al. Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD. Cell Stem Cell. 30: 1299-1314.e9. PMID 37802036 DOI: 10.1016/j.stem.2023.08.014  0.29
2013 Xu CT, Liu H, Gisselsson A, Svenmarker P, Rogelius N, Olsson F, Fredriksson S, Andersson-Engels S. In-vivo high-resolution diffuse luminescence molecular imaging using rare-earth doped upconverting nanoparticles as contrast agents Optical Molecular Probes, Imaging and Drug Delivery, Omp 2013. MW1C.4.  0.013
Hide low-probability matches.